Margaret Pearle, MD PHD
NPI 1790744829 · Urology Physician · Dallas, TX
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1790744829
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD PHD
- Sex
- Female
- Sole proprietor
- No
- License
- J7128 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
751 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 281 | $122 |
| Instillation of Anti-Cancer Drug Into Bladder51720 | 62 | $87 |
| Simple Removal of Foreign Body, Stone, Or Stent in Urethra Or Bladder Using an Endoscope52310 | 51 | $310 |
| Crushing of Stone of Ureter With Insertion of Stent Using an Endoscope52356 | 48 | $404 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 45 | $85 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'S |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Potassium Citratebrand: Potassium Citrate Er | 435 | 145 |
| Indapamide | 227 | 71 |
| Potassium Chloride | 117 | 35 |
| Allopurinol | 77 | 20 |
| Tamsulosin Hcl | 74 | 52 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 59 | 44 |
| Tioproninbrand: Thiola Ec | 58 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$307 across 8 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-03-18
- Last updated
- 2008-04-23
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.